Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Celldex Makes A Bullish Move As It Looks To Take On Regeneron, Sanofi

Celldex could rival a key Regeneron drug, an analyst said Monday as CLDX stock rocketed on the results of multiple studies.

Investors Business Daily

Michelle Mone admits involvement with 'VIP lane' PPE firm for the first time

TORY peer Michelle Mone has admitted her involvement with a “VIP lane” PPE company for the first time.

The National (Scotland)

Cathie Wood's ARK Innovation Just Had Its Best Week Ever Thanks To Roku, These Huge Winners

Cathie Wood's flagship Ark Innovation ETF ARKK just had its best week ever thanks to Roku, DraftKings, Palantir and other huge winners on big news.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Pharma Stocks Providing Consistent Gains for Investors

The pharmaceutical industry is anticipated to be bolstered due to the increasing demand for chronic disease management and the rising requirements of an aging demographic. Given the industry’s solid prospects, investors could buy quality pharma stocks Eton Pharmaceuticals (ETON), Ipsen S.A. (IPSEY), and Merck & Co. (MRK) for consistent gains.…

StockNews.com

3 Pharma Stocks to Capitalize on With Potential Upside

The pharma industry’s prospects look bright, thanks to rising demand for innovative drugs. Thus, pharma stocks with potential upside, like GSK plc (GSK), Johnson & Johnson (JNJ), and Bristol-Myers Squibb Company (BMY), could be wise investments to capitalize on right now. Read on….

StockNews.com

Minister vows to be ‘robust’ in fighting for drugs policy funding

Elena Whitham rejected claims there has been a real-terms cut in investment.

The Independent UK

3 Top-Rated Pharma Stocks Worth Including in Your November Portfolio

The pharmaceutical sector is booming with increasing global healthcare demands and technological progress. Hence, top-rated pharma stocks Dr. Reddy’s (RDY), Novo Nordisk (NVO), and AbbVie (ABBV) might be solid additions to one’s portfolio in November. Read more.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Moderna Tumbles As Light Guidance And Steep Losses Overshadow Sales Beat

Moderna stock tumbled Thursday after the Covid vaccine maker handily beat third-quarter sales forecasts, but issued light guidance.

Investors Business Daily

Regeneron Pharmaceuticals (REGN) Earnings Analysis -- Should Investors Brace for Impact?

Regeneron Pharmaceuticals (REGN) has an impressive revenue and earnings surprise history. So, as the company gears up to post its third-quarter report, is REGN the right pick? Read on.

StockNews.com

Cardinal Health, Cencora Break Out With Assist From GLP-1 Demand

Cardinal Health and Cencora both broke out after topping earnings estimates as both drug-distributors got a boost from GLP-1 weight-loss drugs.

Investors Business Daily

Eli Lilly & Co. (LLY) Earnings Forecast

Drugmaker Eli Lilly and Company (LLY) is scheduled to release its third-quarter results soon. While its revenue is expected to rise sharply over the prior-year quarter, its earnings are expected to decline. So, how should investors position themselves before the results are out? Read on to learn more….

StockNews.com

These 27 eye products could lead to infections and vision loss, FDA warns

If you find one of the products in your home you need to dispose of it immediately, the FDA says

The Independent UK

Verve Stock Soars On $250 Million Eli Lilly Deal

Lilly will pay $250 million to Beam for the rights to three gene-editing drugs from Verve. VERV stock and Beam stock skyrocketed.

Investors Business Daily

Pfizer posts narrower Q3 loss amid slumping Covid vaccine sales

Pfizer, which warned of a $5.5 billion writedown of its Covid treatment inventories earlier this month, posted a narrower-than-expected third quarter loss Tuesday.

The Street

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Pharmacists prescribe another round of US protests to highlight working conditions

Drugstore employees around the country have started calling in sick to highlight a lack of support from their employers

The Guardian - US

White House urges all US schools to stock overdose reversal drug naloxone

Letter from education department presses for schools to train students and faculty in how to administer medication

The Guardian - UK

New Unilever boss is still getting it wrong on Russia

The Dove and Magnum maker says it wants to make a ‘positive impact’ but pays taxes to a state waging an illegal war in Ukraine

StockNews.com

Amgen (AMGN) Earnings Watch: Buy or Sell?

Amgen (AMGN) is scheduled to report its third-quarter earnings soon, with Wall Street analysts expecting year-over-year improvements in revenue. However, its earnings are expected to miss the consensus estimate. Moreover, the company completed the acquisition of Horizon Therapeutics earlier this month. Considering these factors, is the stock a buy or…

Get all your
news in one place.

100’s of premium titles.
One news app.

The National (Scotland)

Life-saving overdose reversal drug expanded across Scotland

Community pharmacies across Scotland are being provided with a drug which can reverse overdoses.

The Independent UK

COVID-19 treatments to enter the market with a hefty price tag

The COVID-19 treatments millions of have taken for free from the federal government will enter the private market next week with a hefty price tag

The Independent UK

US government says it plans to go after legal goods tied to illegal fentanyl trade in new strategy

The U.S. Customs and Border Protection has announced a new government-wide strategy that will target not only fentanyl but precursor materials used to make the synthetic opioid

Investors Business Daily

Biogen Pulls Prothena Into A Steep Dive On Mixed Results For Alzheimer's Treatment

Biogen stock tumbled Thursday — pulling Prothena stock down — on mixed test results for an updated version of its Alzheimer's treatment.

StockNews.com

3 Pharma Stocks With Market Impact to Consider Buying

The pharmaceutical sector is expected to thrive due to the rising demand for advanced medicines to treat lifestyle diseases and its increasing ability to meet quality treatment needs thanks to technological advancements. Therefore, it could be wise to add fundamentally strong pharma stocks Amneal Pharmaceuticals (AMRX), Dr. Reddy’s Laboratories (RDY),…

Investors Business Daily

Cardinal Health Nears Buy Point As Earnings Approach For Drug Distributor

This leading health stock is near all-time highs and in a base. Shares have outperformed the S&P 500 this year.

StockNews.com

3 Pharma Stocks on the Rise - Buy Now

The pharmaceutical industry is well-positioned for long-term growth thanks to rising investments in drug development and technological advancements. Thus, it would be prudent to buy pharma stocks, Sanofi (SNY), Johnson & Johnson (JNJ) and AstraZeneca PLC (AZN). Read on.

1 … 21 22 23 24

People

Cathie Wood

939 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Scottish Government

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.